» Articles » PMID: 16946145

Low-level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-term Neurological Deficits

Overview
Journal Stroke
Date 2006 Sep 2
PMID 16946145
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Low-level laser therapy (LLLT) modulates various biological processes. In the present study, we assessed the hypothesis that LLLT after induction of stroke may have a beneficial effect on ischemic brain tissue.

Methods: Two sets of experiments were performed. Stroke was induced in rats by (1) permanent occlusion of the middle cerebral artery through a craniotomy or (2) insertion of a filament. After induction of stroke, a battery of neurological and functional tests (neurological score, adhesive removal) was performed. Four and 24 hours poststroke, a Ga-As diode laser was used transcranially to illuminate the hemisphere contralateral to the stroke at a power density of 7.5 mW/cm2.

Results: In both models of stroke, LLLT significantly reduced neurological deficits when applied 24 hours poststroke. Application of the laser at 4 hours poststroke did not affect the neurological outcome of the stroke-induced rats as compared with controls. There was no statistically significant difference in the stroke lesion area between control and laser-irradiated rats. The number of newly formed neuronal cells, assessed by double immunoreactivity to bromodeoxyuridine and tubulin isotype III as well as migrating cells (doublecortin immunoactivity), was significantly elevated in the subventricular zone of the hemisphere ipsilateral to the induction of stroke when treated by LLLT.

Conclusions: Our data suggest that a noninvasive intervention of LLLT issued 24 hours after acute stroke may provide a significant functional benefit with an underlying mechanism possibly being induction of neurogenesis.

Citing Articles

Potential and Challenges of Transcranial Photobiomodulation for the Treatment of Stroke.

Li S, Wong T, Ng S CNS Neurosci Ther. 2024; 30(12):e70142.

PMID: 39692710 PMC: 11653948. DOI: 10.1111/cns.70142.


Therapeutic Potentials of Near-Infrared II Photobiomodulation to Treat Cerebrovascular Diseases via Nitric Oxide Signalling.

Kashiwagi S, Yokomizo S, Bragin D, Perle S, Kastanenka K, Gerashchenko D Adv Exp Med Biol. 2024; 1463:195-200.

PMID: 39400823 PMC: 11670881. DOI: 10.1007/978-3-031-67458-7_33.


Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics.

Nairuz T, Sangwoo-Cho , Lee J Cells. 2024; 13(11.

PMID: 38891098 PMC: 11171912. DOI: 10.3390/cells13110966.


Near-Infrared II Photobiomodulation Preconditioning Ameliorates Stroke Injury via Phosphorylation of eNOS.

Yokomizo S, Kopp T, Roessing M, Morita A, Lee S, Cho S Stroke. 2024; 55(6):1641-1649.

PMID: 38572660 PMC: 11126363. DOI: 10.1161/STROKEAHA.123.045358.


Effects of photobiomodulation on pain, lactate and muscle performance (ROM, torque, and EMG parameters) of paretic upper limb in patients with post-stroke spastic hemiparesis-a randomized controlled clinical trial.

das Neves M, Pinto A, Maegima L, Silva Lima F, Lopes-Martins R, Lo Schiavo Arisawa E Lasers Med Sci. 2024; 39(1):88.

PMID: 38453765 DOI: 10.1007/s10103-024-04035-w.